LQB-118
LQB-118 is an orally active compound derived from sandalwood. LQB-118 can inhibit the migration of glioblastoma cells and induce cell death. LQB-118 can suppress the migration and invasion of prostate cancer cells by regulating the AKT/GSK3β pathway and the expression of the MMP-9/reck genes. LQB-118 can also inhibit yeast polysaccharide-induced inflammation both in vivo and in vitro. Additionally, LQB-118 selectively induces ROS-triggered and mitochondrial-dependent apoptosis in Leishmania amazonensis. LQB-118 can be used in studies related to inflammation, infections, and cancer diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1219104-20-7
- Formel: C19H12O4
- Molecular Weight:304.30
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
11.21 μM
Compound: 5a
|
Growth inhibition of human A549 cells after 72 hrs by MTT assay
Growth inhibition of human A549 cells after 72 hrs by MTT assay
|
[PMID: 20117936] |
| Daudi | IC50 |
3.1 μM
Compound: 5a
|
Growth inhibition of human Daudi cells after 24 to 72 hrs by MTT assay
Growth inhibition of human Daudi cells after 24 to 72 hrs by MTT assay
|
[PMID: 20117936] |
| GLC4 cell line | IC50 |
5.17 μM
Compound: 5a
|
Growth inhibition of human GLC4 cells after 72 hrs by MTT assay
Growth inhibition of human GLC4 cells after 72 hrs by MTT assay
|
[PMID: 20117936] |
| HCT-8 | IC50 |
2.6 μM
Compound: (+/-)-1a
|
Antineoplastic activity against human HCT8 cells after 72 hrs by MTT assay
Antineoplastic activity against human HCT8 cells after 72 hrs by MTT assay
|
[PMID: 22000949] |
| HL-60 | IC50 |
1.3 μM
Compound: (+/-)-1a
|
Antineoplastic activity against human HL60 cells after 72 hrs by MTT assay
Antineoplastic activity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 22000949] |
| HL-60 | IC50 |
2 μM
Compound: 5a
|
Growth inhibition of human HL60 cells after 72 hrs by MTT assay
Growth inhibition of human HL60 cells after 72 hrs by MTT assay
|
[PMID: 20117936] |
| J774 | IC50 |
12.7 μM
Compound: (+/-)-1a
|
Selectivity index, ratio of IC50 for mouse J774 cells to IC50 for Leishmania amazonensis amastigotes infected in BALB/c mouse macrophages
Selectivity index, ratio of IC50 for mouse J774 cells to IC50 for Leishmania amazonensis amastigotes infected in BALB/c mouse macrophages
|
[PMID: 22000949] |
| J774 | IC50 |
18.5 μM
Compound: (+/-)-1a
|
Cytotoxicity against mouse J774 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774 cells after 72 hrs by MTT assay
|
[PMID: 22000949] |
| Jurkat | IC50 |
6.77 μM
Compound: 5a
|
Growth inhibition of human Jurkat cells after 24 to 72 hrs by MTT assay
Growth inhibition of human Jurkat cells after 24 to 72 hrs by MTT assay
|
[PMID: 20117936] |
| K562 | IC50 |
1.67 μM
Compound: (+/-)-1a
|
Antineoplastic activity against human K562 cells after 72 hrs by MTT assay
Antineoplastic activity against human K562 cells after 72 hrs by MTT assay
|
[PMID: 22000949] |
| K562 | IC50 |
1.67 μM
Compound: 5a
|
Growth inhibition of human K562 cells after 24 to 72 hrs by MTT assay
Growth inhibition of human K562 cells after 24 to 72 hrs by MTT assay
|
[PMID: 20117936] |
| K562-Lucena 1 | IC50 |
2.75 μM
Compound: 5a
|
Growth inhibition of human K562-Lucena 1 cells after 24 to 72 hrs by MTT assay
Growth inhibition of human K562-Lucena 1 cells after 24 to 72 hrs by MTT assay
|
[PMID: 20117936] |
| LNCaP | IC50 |
1.1 μg/mL
Compound: LQB-118, LQB
|
Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Cytotoxicity against human LNCAP cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 24794748] |
| MDA-MB-435 | IC50 |
2.3 μM
Compound: (+/-)-1a
|
Antineoplastic activity against human MDA-MB-435 cells after 72 hrs by MTT assay
Antineoplastic activity against human MDA-MB-435 cells after 72 hrs by MTT assay
|
[PMID: 22000949] |
| NCI-H460 | IC50 |
12.86 μM
Compound: 5a
|
Growth inhibition of human H460 cells after 72 hrs by MTT assay
Growth inhibition of human H460 cells after 72 hrs by MTT assay
|
[PMID: 20117936] |
| PBMC | IC50 |
>20 μM
Compound: (+/-)-1a
|
Cytotoxicity against PHA activated human PBMC cells after 72 hrs by MTT assay
Cytotoxicity against PHA activated human PBMC cells after 72 hrs by MTT assay
|
[PMID: 22000949] |
| PBMC | IC50 |
>20 μM
Compound: 5a
|
Growth inhibition of phytohemagglutinin-activated human PBMC cells after 24 to 72 hrs by MTT assay
Growth inhibition of phytohemagglutinin-activated human PBMC cells after 24 to 72 hrs by MTT assay
|
[PMID: 20117936] |
| PC-3 | IC50 |
1.7 μg/mL
Compound: LQB-118, LQB
|
Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 24794748] |
| Raji | IC50 |
3.32 μM
Compound: 5a
|
Growth inhibition of human Raji cells after 24 to 72 hrs by MTT assay
Growth inhibition of human Raji cells after 24 to 72 hrs by MTT assay
|
[PMID: 20117936] |
| RWPE-1 | IC50 |
1.3 μg/mL
Compound: LQB-118, LQB
|
Cytotoxicity against human RWPE1 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Cytotoxicity against human RWPE1 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 24794748] |
| SF-295 | IC50 |
3.6 μM
Compound: (+/-)-1a
|
Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay
Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay
|
[PMID: 22000949] |
Chemical Information
-
CAS. Nr. 1219104-20-7
-
Molecular Weight 304.30
-
Formel C19H12O4
-
SMILES
O=C1C2=C(C(C3=CC=CC=C31)=O)OC[C@@]4([H])[C@]2([H])OC5=CC=CC=C45
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
Reinheit & Dokumentation
Verweise
[1]. Bernardo PS, et al. LQB‑118 compound inhibits migration and induces cell death in glioblastoma cells. Oncol Rep. 2020 Jan;43(1):346-357. [Content Brief]
[2]. Martino T, et al. LQB-118 Suppresses Migration and Invasion of Prostate Cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression. Anticancer Res. 2023 Jan;43(1):359-367. [Content Brief]
[3]. Lima ÉA, et al. The pterocarpanquinone LQB 118 inhibits inflammation triggered by zymosan in vivo and in vitro. Int Immunopharmacol. 2020 Jun;83:106399. [Content Brief]
[4]. Ribeiro GA, et al. LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis. J Antimicrob Chemother. 2013 Apr;68(4):789-99. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)